Drug profile · INN
peginterferon alfa-2b
CYLATRON
peginterferon alfa-2b (CYLATRON) is a interferon alpha/beta receptor agonist. Current US regulatory status: approved.
Drug details — peginterferon alfa-2b
- US status
- approved
- Class
- Antineoplastic and immunomodulating agents (L03)
- Route
- —
- Patents
- 0
- Programs
- 2
- Data quality
- 0.83
Quick answer
peginterferon alfa-2b (CYLATRON) is a interferon alpha/beta receptor agonist. Current US regulatory status: approved.
Key facts
Mechanism of action
Interferon alpha/beta receptor agonist
Primary target: Interferon alpha/beta receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is peginterferon alfa-2b?
peginterferon alfa-2b (CYLATRON) is a interferon alpha/beta receptor agonist. Current US regulatory status: approved.
What is the brand name for peginterferon alfa-2b?
CYLATRON is a marketed brand name for peginterferon alfa-2b. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of peginterferon alfa-2b?
peginterferon alfa-2b has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.